The table below shows Relay Therapeutics, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$51.11M
-$73.21M
-$50.32M
-$67.13M
-$49.17M
$46.64M
Capital expenditure
-
$384.00K
$1.78M
$1.92M
$2.79M
$476.00K
Investing cash flow
$32.90M
$42.47M
$10.53M
$75.31M
-$112.38M
-$233.62M
Dividends paid
-
-
-
-
RLAY operating cash flow (10-K history)
Relay Therapeutics, Inc. reported operating cash flow of -$235.46M for fiscal year 2025. That is up 5.5% from -$249.11M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$66.13M (FY 2019) to -$235.46M. Figures come from the company's audited annual reports as filed with the SEC.
